WaveMan
WaveMan · Company
SPRC · Scisparc Ltd.
> Search tickers & screens ⌘K
LIVE
← All companies

SPRC SciSparc (SPRC) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Pharmaceutical preparations · CIK 0001611746
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
8
13F, latest reported quarter

What the filings say about SPRC

Insiders, 180 days
-$4.6K net sold
1 seller · 0% of sales under a 10b5-1 plan

SciSparc insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, SciSparc Ltd. insiders sold a net $4.6K of stock across 1 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
SELL
2026-06-03 SECtraded 2026-06-01
462
$4.6K
-88.8%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 4.4% of the 10,596 shares held after it.
  • No other insider sold within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Shrem Itschak sold about $4.6K of SPRC on Jun 1, 2026, the largest insider sale at the company on our record; 8 funds added in the latest 13F quarter.
1 transaction on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$4.6K over 180 days
more than 62% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
8 funds bought in last quarter
below 89% of Pharma & Biotech
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
2.2% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
below 57% of Pharma & Biotech
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch SPRC

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-96.4%12M
-97%-64%-32%+1%2025-102025-122026-022026-042026-062026-082026-10 2026-06-01 · Shrem Itschak sold $4.6K2026-06-22 · SMITH JAMES EDMOND filed to sell $583.9K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns SPRC: institutional holders (13F)

13F holdings, latest reported quarter
$91.1K
$61.1K
4,518 sh
$24.9K
$1.1K

Congress trades in SPRC

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

SPRC planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
SMITH JAMES EDMOND
Filed 2026-06-22
$583.9K
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $4.6K sold by insiders over 180 days, 8 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

SPRC financials

Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2024-122023-122022-122021-12
Gross profit$506.0K$2.2M$1.0Mn/a
Net income-$7.5M-$5.9M-$2.6M-$5.8M
SEC XBRL, fiscal years, as known on 2026-10-28

SPRC Stock Sonar score 3/7 axes

Find similar shapesCompare

SPRC ranks highest on risk and compliance (72nd percentile) and insider conviction (30th), and lowest on institutional and government (11th), among Pharma & Biotech peers.

Insider conviction
30
Inputs
  • Net Form 4 buying (codes P and S), 180d-$5K · 61 pct, sector of 429
  • Insider buyers, 180d0 · 0 pct, sector of 438
Institutional and government
11
Inputs
  • Funds adding, latest quarter8 · 11 pct, sector of 698
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
72
Inputs
  • Short interest, % of float+2.2% · 72 pct, sector of 816
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Growth, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

SPRC filings, in plain words

Are SciSparc insiders buying or selling SPRC?

In the 180 days to 2026-10-28, SciSparc insiders were net sellers, a net $4.6K across purchases and sales reported on Form 4, by 1 seller.

Read the full summary

In the 180 days to 2026-10-28, SciSparc insiders were net sellers of SPRC, a net $4.6K across purchases and sales reported on Form 4 by 1 seller. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing